CollPlant Biotechnologies (CLGN)
(Delayed Data from NSDQ)
$4.62 USD
+0.12 (2.56%)
Updated Aug 7, 2024 10:53 AM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Brokerage Reports
0 items in cart
CollPlant Biotechnologies Ltd. Sponsored ADR [CLGN]
Reports for Purchase
Showing records 21 - 40 ( 52 total )
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: CollPlant Reports 2021 Results Lowering our PT: $20 to $17
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
CollPlant Inks a Deal with CELLINK-3D Bioprinter
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: Reports the Quarter Maintains Cash Balance at $46M
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
New Collaboration for Breast Reconstruction Products; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: BioPrinted Solutions for Breast Reconstruction 3D Systems and CollPlant Enter Co-Development Agreement
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Additional Milestone Payments Could Be Triggered in 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: 1Q21 Results Produces Positive Net Income
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Potential Allergan Milestone Payment Expected in 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: United Walks Away -10% Chance, So No Real Impact
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: United Walks Away 10% Chance, So No Real Impact
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Allergan Deal Could Be the Conduit to the Large Aesthetic Market; Higher $26 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: Allergan and AbbVie Come on Board With $14M Upfront
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: Expands the Collaboration with United Therapeutics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Awaiting a Major Licensing Agreement; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
BUY: Expands the Collaboration with United Therapeutics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: CollPlant Biotechnologies Ltd. Sponsored ADR
Industry: Medical - Drugs
Pipeline Development on Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S